Adenosine deaminase is a useful biomarker to diagnose pleural tuberculosis in low to medium prevalence settings

Diagn Microbiol Infect Dis. 2016 Mar;84(3):215-20. doi: 10.1016/j.diagmicrobio.2015.11.007. Epub 2015 Nov 10.

Abstract

Adenosine deaminase (ADA) activity measurement in pleural fluid is a relevant test to diagnose pleural tuberculosis (pTB) in high tuberculosis prevalence settings. We investigated the diagnostic utility of pleural ADA using a retrospective analysis of patients admitted with newly diagnosed pleural effusion without identified etiology between 2001 and 2008 in Paris suburb, a low to medium tuberculosis prevalence area. 104 adults (mean age 55 years; 34 with pTB, 70 with other diagnoses) were analyzed. Median follow-up was 15.6 months. Mean [interquartile range] pleural ADA was 119 U/L [IQR: 83-143] in pTB and 24 U/L [IQR: 15-31] in non-tuberculous effusions (P<0.001). With an optimal pleural ADA cut-off value of 41.5 U/L for pTB diagnosis, sensitivity and specificity were 97.1% and 92.9%, while positive and negative predictive values were 86.8% and 98.5%, respectively. We conclude that pleural ADA activity could be integrated in the diagnostic procedures of pTB in low to medium tuberculosis prevalence settings.

Keywords: Biological marker; Mycobacterium tuberculosis; Pleural effusion.

MeSH terms

  • Adenosine Deaminase / metabolism*
  • Adult
  • Aged
  • Biomarkers*
  • Enzyme Activation
  • Female
  • Follow-Up Studies
  • France / epidemiology
  • Humans
  • Male
  • Middle Aged
  • Odds Ratio
  • Pleural Effusion / enzymology*
  • Pleural Effusion, Malignant / enzymology
  • Prevalence
  • ROC Curve
  • Retrospective Studies
  • Risk Factors
  • Tuberculosis, Pleural / diagnosis*
  • Tuberculosis, Pleural / epidemiology
  • Tuberculosis, Pleural / metabolism*
  • Tuberculosis, Pleural / microbiology

Substances

  • Biomarkers
  • Adenosine Deaminase